165 related articles for article (PubMed ID: 7903830)
1. Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection.
Sloand E; Kumar P; Klein HG; Merritt S; Sacher R
Transfusion; 1994 Jan; 34(1):48-53. PubMed ID: 7903830
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial.
Collier AC; Kalish LA; Busch MP; Gernsheimer T; Assmann SF; Lane TA; Asmuth DM; Lederman MM; Murphy EL; Kumar P; Kelley M; Flanigan TP; McMahon DK; Sacks HS; Kennedy MS; Holland PV;
JAMA; 2001 Mar; 285(12):1592-601. PubMed ID: 11268267
[TBL] [Abstract][Full Text] [Related]
3. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
[TBL] [Abstract][Full Text] [Related]
5. Patterns of opportunistic infections in patients with HIV infection.
Finkelstein DM; Williams PL; Molenberghs G; Feinberg J; Powderly WG; Kahn J; Dolin R; Cotton D
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):38-45. PubMed ID: 8624759
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.
Hoover DR; Peng Y; Saah A; Semba R; Detels RR; Rinaldo CR; Phair JP
Arch Ophthalmol; 1996 Jul; 114(7):821-7. PubMed ID: 8660165
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus infection in children.
Hoernle EH; Reid TE
Am J Health Syst Pharm; 1995 May; 52(9):961-79. PubMed ID: 7641035
[TBL] [Abstract][Full Text] [Related]
8. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of preventing AIDS-related opportunistic infections.
Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group.
Burke M; Yust I; Katlama C; Vardinon N; Clumeck N; Pinching AJ; Ledergerber B; Gatell JM; Chiesi A; Barton SE; Lundgren JD; Pedersen C
Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):876-82. PubMed ID: 9495667
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
12. Profile of opportunistic infections among HIV-1 infected people in Hong Kong.
Wong KH; Lee SS; Lo YC; Li PC; Ho HF; Sitt WH; Lam TW; Lai KY
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Feb; 55(2):127-36. PubMed ID: 7750052
[TBL] [Abstract][Full Text] [Related]
13. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.
Williams PL; Currier JS; Swindells S
AIDS; 1999 Jun; 13(9):1035-44. PubMed ID: 10397533
[TBL] [Abstract][Full Text] [Related]
14. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.
Yazdanpanah Y; Chêne G; Losina E; Goldie SJ; Merchadou LD; Alfandari S; Seage GR; Sullivan L; Marimoutou C; Paltiel AD; Salamon R; Mouton Y; Freedberg KA
Int J Epidemiol; 2001 Aug; 30(4):864-71. PubMed ID: 11511618
[TBL] [Abstract][Full Text] [Related]
15. Role of CD8+ in late opportunistic infections of patients with AIDS.
Fiala M; Kermani V; Gornbein J
Res Immunol; 1992; 143(9):903-7. PubMed ID: 1363252
[TBL] [Abstract][Full Text] [Related]
16. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
[TBL] [Abstract][Full Text] [Related]
17. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS.
Chan IS; Neaton JD; Saravolatz LD; Crane LR; Osterberger J
AIDS; 1995 Oct; 9(10):1145-51. PubMed ID: 8519450
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-acquired AIDS in Taiwan.
Yao C; Wang WW; Chung YM; Su YL; Liu CY; Chen YM
J Formos Med Assoc; 1996 Jan; 95(1):51-5. PubMed ID: 8640096
[TBL] [Abstract][Full Text] [Related]
20. Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds.
Dworkin MS; Hanson DL; Kaplan JE; Jones JL; Ward JW
J Infect Dis; 2000 Aug; 182(2):611-5. PubMed ID: 10915098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
